Landmark Health, a healthcare company backed by private equity firms such as McKesson Ventures, is exploring the possibility of a sale. This would free up Landmark CEO Adam Boehler to head the Center for Medicare and Medicaid Innovation (CMMI). Back in December, Politico reported that Boehler is at the top of the list for the role.
Though Landmark has made no official statement on the sale, many are speculating that Boehler would be an asset in the position of head of CMMI, coming as he does from an entrepreneurial background based in home care. He has been a leader at Landmark during the development of Landmark’s innovative alternative payment models, including accountable care organizations (ACOs) and bundled payment programs. These are particularly popular amongst providers, who see them as a way to incentivize low-cost care that allows patients to remain in their homes.
Landmark Health was funded in 2013 and serves Oregon, California, Washington, New York, Massachusetts, and Pennsylvania. The company works with physician groups, health systems, and other organizations to provide in-home care for chronically ill patients. In 2016, Landmark enrolled its 5,000th patient.
Landmark is projected to generate about $53 million in 2018.